["{\n\"step_by_step_thinking\": \"The provided documents do not mention Axitinib or its relation to Pancreatic Cancer patients. Therefore, it is necessary to rely on external information to answer the question. A review of ubenimex (Bestatin) and its role in prolonging survival duration in adult acute nonlymphocytic leukemia patients is available. Similarly, studies on the mechanism of action of cetraxate, a new anti-ulcer agent, have been conducted. However, these studies do not provide any information about Axitinib or its effects on Pancreatic Cancer patients. Therefore, it is impossible to determine whether Axitinib prolongs survival of Pancreatic Cancer patients based on the provided documents.\",\n\"answer_choice\": \"B\"\n}"]